MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-06-0020148
Cureclip Pharmaceuticals Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹39.18 Lakh
▼ 94% YoY
Net loss · FY 2025
₹62.01 Lakh
Net margin -158.3%
EBITDA · FY 2025
₹16.93 Lakh
EBITDA margin 43.2%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹57.29 Lakh
Issued & subscribed
Open charges
₹2.1 Cr
Satisfied ₹12.12 Cr
Company age
36 yrs
Est. 1990
Directors on board
3
As per MCA filings
About Cureclip Pharmaceuticals Limited
Data last updated:
Cureclip Pharmaceuticals Limited is a public limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 November 1990 and has been in existence for over 36 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL1990PLC042161. Its GSTIN is 07AAACM1637L1ZG (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹57.29 Lakh. It is led by directors including Vivek Goyal and Naresh Kumar Goyal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No. 1273 12th Floor Aggarwal Cyber Plaza 2 Netaji Subash Place Pitampura, Delhi, India – 110034.
As per the financials filed for FY 2025, the company reported a revenue of ₹39.18 Lakh, a decline of 94% compared to the previous year. For the same year it recorded a net loss of ₹62.01 Lakh (net margin -158.3%) and EBITDA of ₹16.93 Lakh (EBITDA margin 43.2%). Revenue has declined at a compounded annual rate (CAGR) of 79% over three years and 59% over five years.
The company is associated with 1 brand: Maiden Pharmaceuticals. As per MCA filings, the company has open charges of ₹2.1 Cr and satisfied charges of ₹12.12 Cr on record. Court records list 32 cases involving the company, including 6 filed by the company and 26 filed against it; 4 cases are pending.
Cureclip Pharmaceuticals Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0020148). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website maidenpharma.com.
Company details
CIN U24230DL1990PLC042161
Registration Number 042161
Incorporation Date 22 November 1990
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-06-0020148
Recognitions & Rankings of Cureclip Pharmaceuticals
Contact details
Cureclip Pharmaceuticals Limited's registered office is in Delhi, Delhi. Its website is maidenpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressUnit No. 1273 12th Floor Aggarwal Cyber Plaza 2 Netaji Subash Place Pitampura, Delhi, India – 110034
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Cureclip Pharmaceuticals Limited, buy the company report.
Comprehensive company report
Cureclip Pharmaceuticals Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Cureclip Pharmaceuticals operates one associated brand: Maiden Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of drugs | maidenpharma.com |
Business activity
The main business activity of Cureclip Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Cureclip Pharmaceuticals Limited, buy the company report.
Financials of Cureclip Pharmaceuticals Limited
FY 2025 filings availableCureclip Pharmaceuticals Limited reported revenue of ₹39.18 Lakh (down 94% YoY) for FY 2025.
Revenue · FY 2025
₹39.18 Lakh ▼ 94%
Net loss · FY 2025
₹62.01 Lakh margin -158.3%
EBITDA · FY 2025
₹16.93 Lakh margin 43.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 94%
3 years · compounded
▼ 79%
5 years · compounded
▼ 59%
EBITDA CAGR growth
1 year
▼ 87%
3 years · compounded
▼ 53%
5 years · compounded
▼ 24%
Revenue has declined at a compounded annual rate (CAGR) of 59% over five years, including a 94% fall in the latest year. EBITDA fell 87% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹16.93 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹62.01 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 43.2% | ||||
| Net Profit Margin | -158.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cureclip Pharmaceuticals Limited, buy the company report.
Board of directors of Cureclip Pharmaceuticals Limited
Cureclip Pharmaceuticals has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vivek Goyal | Director | 15 Dec 2016 | 9 Years 10 Months | Current |
| Naresh Kumar Goyal Also directs: DJ Biotech LLP, DJ Biotech Private Limited, Intact Drugs and Pharmaceuticlas Pvt.Ltd. and 2 more | Director | 01 Nov 2005 | 20 Years 11 Months | Current |
| Manoj Kumar Jha Also directs: Real Drugs Private Limited | Additional Director | 01 Apr 2025 | 1 Years 6 Months | Current |
Auditor
Cureclip Pharmaceuticals Limited is audited by R. P. NARANG & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R. P. NARANG & Co. | FY 2023 | 001794N |
Shareholding
The shareholding of Cureclip Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cureclip Pharmaceuticals Limited, buy the company report.
Charges & borrowings
Open charges
₹2.1 Cr
Satisfied charges
₹12.12 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Jan 2022 | 100567304 | Axis Bank Limited | ₹1.5 Cr | Open | |
| 26 Jul 2021 | 100470437 | Others | ₹60 Lakh | Open | |
| 26 Feb 2022 | 100548885 | Others | ₹4.99 Cr | Satisfied | |
| 28 Aug 2002 | 80051104 | Punjab & Sind Bank | ₹4.6 Cr | Satisfied | |
| 28 Aug 2002 | 90054628 | Punjab & Sind Bank | ₹75 Lakh | Satisfied |
To see the full charge records of Cureclip Pharmaceuticals Limited, buy the company report.
Total charge records: 8 View all charges
Legal cases
Cureclip Pharmaceuticals Limited has 32 court cases on record: 6 filed by Cureclip Pharmaceuticals, 26 filed against it. 4 cases are pending and 28 are disposed.
Total cases
32
Filed by the company
6
Filed against the company
26
Pending
4
Disposed
28
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 24 | 20 | 2 |
| District courts | 7 | 6 | 2 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 32)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Court case (C.O.(COMM.IPD-CR)) | Filed by the company against Hab Pharmaceuticals and Research Ltd and Anr | Disposed |
| High Court of Delhi | Commercial suit | Filed against the company by M/S Arbro Pharmaceuticals Ltd. | Disposed |
| Supreme Court | Court case (2804-Mercantile Laws, Commercial Transactions Including Banking : Trade Marks/Copy Rights/Patents/Design Act) | Filed by the company against Arbro Pharmaceuticals Ltd | Disposed |
| High Court of Delhi | Court case (CS(OS)) | Filed against the company by Ranbaxy Laboratories Ltd | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Civil suit | Filed against the company by Ajanta Pharma Ltd | Disposed |
To see the full case history of Cureclip Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cureclip Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cureclip Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACM1637L1ZG | Delhi | Active | 01 Jul 2017 |
| 06AAACM1637L1ZI | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Cureclip Pharmaceuticals Limited, buy the company report.
Recent activity
Cureclip Pharmaceuticals Limited has 17 board changes on record since 1992: 10 appointments and 7 cessations. The latest: Rakhi ceased to be Director on 23 May 2025.
AGM
Cureclip Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Rakhi ceased to be Director.
Appointed
Manoj Kumar Jha was appointed as Additional Director.
Filing
Cureclip Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge registered on 26 Feb 2022 via Charge ID 100548885 with Others was fully satisfied on 17 Feb 2023.
Ceased
Kapil Goyal ceased to be Director.
Appointed
Rakhi was appointed as Director.
Charges
A charge with Others of Rs. 4.99 Cr registered on 26 Feb 2022 with Charge ID 100548885 was modified on 22 Apr 2022.
Charges
A charge registered on 28 Aug 2002 via Charge ID 90054628 with Punjab & Sind Bank was fully satisfied on 21 Apr 2022.
Charges
A charge registered on 28 Aug 2002 via Charge ID 80051104 with Punjab & Sind Bank was fully satisfied on 21 Apr 2022.
Charges
A charge registered on 22 Aug 2001 via Charge ID 90054291 with Punjab & Sind Bank was fully satisfied on 21 Apr 2022.
Charges
A charge registered on 22 Sep 1999 via Charge ID 90053703 with Punjab & Sind Bank was fully satisfied on 21 Apr 2022.
25 earlier events are in the company report.
Frequently asked questions
Cureclip Pharmaceuticals is an active public limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 November 1990 (36+ years old) and is registered under CIN U24230DL1990PLC042161.
Cureclip Pharmaceuticals has 3 current directors:
- Vivek Goyal - Director
- Naresh Kumar Goyal - Director
- Manoj Kumar Jha - Additional Director
The latest financial statements of Cureclip Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Cureclip Pharmaceuticals is 07AAACM1637L1ZG, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 06AAACM1637L1ZI (Haryana).
The CIN (Corporate Identification Number) of Cureclip Pharmaceuticals is U24230DL1990PLC042161. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cureclip Pharmaceuticals has 32 court cases on record: 6 filed by the company and 26 filed against it. 4 are pending. Most are in the high courts.
Cureclip Pharmaceuticals was incorporated on 22 November 1990, making it 36+ years old. It is registered with the Registrar of Companies, Delhi.
Rakhi ceased to be Director on 23 May 2025. Manoj Kumar Jha was appointed as Additional Director on 01 Apr 2025. Kapil Goyal ceased to be Director on 28 Sep 2022. Cureclip Pharmaceuticals has 17 board changes on record in total.
Yes, Cureclip Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-DL-06-0020148).
Cureclip Pharmaceuticals can be reached through the website maidenpharma.com. Its registered office is in Delhi, India.